Everolimus use and associated factors among post-menopausal women with hormonal receptor positive/human epidermal growth factor receptor 2 negative metastatic breast cancer. [electronic resource]
Producer: 20160401Description: 1573-82 p. digitalISSN:- 1473-4877
- Adult
- Aged
- Aged, 80 and over
- Androstadienes -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Breast Neoplasms -- chemistry
- Everolimus -- therapeutic use
- Female
- Humans
- Liver Neoplasms -- secondary
- Middle Aged
- Receptor, ErbB-2 -- analysis
- Receptors, Estrogen -- analysis
- Retrospective Studies
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.